Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 729 JPY 0.26% Market Closed
Market Cap: 425.9B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

173B
-2%
Revenue
Growth Rates:
1 Year
+3%
3 Years
+14%
5 Years
+4%
7 Years
+15%
10 Years
+36%
24.8B
-4%
Operating Income
Growth Rates:
1 Year
-9%
3 Years
-4%
5 Years
-4%
7 Years
+21%
10 Years
+42%
13.9B
-21%
Net Income
Growth Rates:
1 Year
-31%
3 Years
-26%
5 Years
-24%
7 Years
-14%
10 Years
+18%

Earnings Waterfall
Kobayashi Pharmaceutical Co Ltd

Revenue
173B JPY
Cost of Revenue
-78.3B JPY
Gross Profit
94.6B JPY
Operating Expenses
-69.8B JPY
Operating Income
24.8B JPY
Other Expenses
-10.9B JPY
Net Income
13.9B JPY

Income Statement
Kobayashi Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
127 256
N/A
127 574
+0%
128 721
+1%
128 344
0%
131 144
+2%
133 385
+2%
135 798
+2%
137 211
+1%
144 007
+5%
148 008
+3%
120 051
-19%
150 800
+26%
150 591
0%
153 338
+2%
156 761
+2%
159 727
+2%
162 132
+2%
164 876
+2%
167 479
+2%
165 441
-1%
166 373
+1%
167 442
+1%
158 340
-5%
274 305
+73%
268 679
-2%
263 389
-2%
150 514
-43%
148 872
-1%
151 386
+2%
153 123
+1%
155 252
+1%
157 629
+2%
159 464
+1%
161 873
+2%
166 258
+3%
167 079
+0%
168 619
+1%
171 094
+1%
173 455
+1%
176 473
+2%
172 966
-2%
Gross Profit
Cost of Revenue
(54 012)
(54 191)
(54 887)
(54 718)
(56 129)
(56 931)
(57 528)
(57 518)
(59 507)
(60 757)
(48 638)
(60 084)
(59 416)
(59 838)
(61 238)
(62 230)
(62 839)
(63 719)
(64 359)
(64 896)
(65 188)
(65 357)
(67 364)
(111 660)
(111 532)
(111 154)
(65 248)
(64 036)
(64 926)
(65 707)
(66 478)
(68 007)
(69 382)
(71 150)
(73 927)
(74 060)
(74 727)
(76 017)
(77 079)
(78 474)
(78 324)
Gross Profit
73 244
N/A
73 383
+0%
73 834
+1%
73 626
0%
75 015
+2%
76 454
+2%
78 270
+2%
79 693
+2%
84 500
+6%
87 251
+3%
71 413
-18%
90 716
+27%
91 175
+1%
93 500
+3%
95 523
+2%
97 497
+2%
99 293
+2%
101 157
+2%
103 120
+2%
100 545
-2%
101 185
+1%
102 085
+1%
90 976
-11%
162 645
+79%
157 147
-3%
152 235
-3%
85 266
-44%
84 836
-1%
86 460
+2%
87 416
+1%
88 774
+2%
89 622
+1%
90 082
+1%
90 723
+1%
92 331
+2%
93 019
+1%
93 892
+1%
95 077
+1%
96 376
+1%
97 999
+2%
94 642
-3%
Operating Income
Operating Expenses
(55 738)
(55 926)
(55 826)
(55 709)
(55 972)
(57 108)
(58 628)
(61 433)
(63 394)
(66 517)
(54 004)
(68 349)
(70 702)
(70 803)
(72 598)
(73 963)
(75 129)
(75 814)
(76 831)
(74 670)
(75 211)
(75 201)
(65 318)
(117 103)
(112 394)
(107 062)
(59 323)
(59 079)
(60 497)
(61 562)
(62 709)
(63 401)
(64 389)
(65 335)
(65 662)
(66 134)
(66 685)
(67 770)
(70 596)
(72 252)
(69 797)
Selling, General & Administrative
(55 736)
(55 925)
(55 826)
(49 255)
(55 972)
(57 107)
(58 627)
(54 525)
(63 392)
(66 517)
(48 844)
(66 871)
(69 227)
(69 325)
(64 023)
(73 962)
(75 126)
(75 813)
(68 642)
(74 668)
(75 209)
(75 199)
(56 920)
(117 102)
(112 392)
(107 060)
(50 843)
(59 077)
(60 496)
(61 561)
(52 790)
(63 400)
(64 387)
(65 333)
(54 669)
(66 133)
(66 684)
(67 769)
(58 387)
(72 251)
(69 797)
Research & Development
0
0
0
(5 289)
0
0
0
(5 788)
0
0
(4 121)
0
0
0
(7 239)
0
0
0
(7 031)
0
0
0
(7 110)
0
0
0
(7 338)
0
0
0
(7 522)
0
0
0
(8 327)
0
0
0
(9 004)
0
0
Depreciation & Amortization
0
0
0
(1 164)
0
0
0
(1 119)
0
0
(1 038)
0
0
0
(1 334)
0
0
0
(1 157)
0
0
0
(1 287)
0
0
0
(1 141)
0
0
0
(2 395)
0
0
0
(2 666)
0
0
0
(3 204)
0
0
Other Operating Expenses
(2)
(1)
0
(1)
0
(1)
(1)
(1)
(2)
0
(1)
(1 478)
(1 475)
(1 478)
(2)
(1)
(3)
0
(1)
(1)
(1)
0
(1)
0
(2)
0
(1)
(2)
0
(1)
(2)
0
(2)
(2)
0
(1)
(1)
0
(1)
(1)
0
Operating Income
17 506
N/A
17 457
0%
18 008
+3%
17 917
-1%
19 043
+6%
19 346
+2%
19 642
+2%
18 260
-7%
21 106
+16%
20 734
-2%
17 409
-16%
22 367
+28%
20 473
-8%
22 697
+11%
22 925
+1%
23 534
+3%
24 164
+3%
25 343
+5%
26 289
+4%
25 875
-2%
25 974
+0%
26 884
+4%
25 658
-5%
45 542
+77%
44 753
-2%
45 173
+1%
25 943
-43%
25 757
-1%
25 963
+1%
25 854
0%
26 065
+1%
26 221
+1%
25 693
-2%
25 388
-1%
26 669
+5%
26 885
+1%
27 207
+1%
27 307
+0%
25 780
-6%
25 747
0%
24 845
-4%
Pre-Tax Income
Interest Income Expense
372
550
661
1 534
422
(97)
(189)
(217)
(418)
(17)
2 363
471
806
858
412
404
437
417
352
506
614
708
1 179
1 715
1 609
1 531
771
1 160
1 094
1 112
1 052
781
1 185
1 291
835
684
602
957
1 209
1 504
1 458
Non-Reccuring Items
209
49
529
282
1 081
1 197
719
(502)
(937)
(1 236)
(1 386)
428
569
954
(1 526)
(1 539)
(1 885)
(2 251)
(1 966)
(2 336)
(2 190)
(1 853)
(1 872)
(2 573)
(2 001)
(2 022)
(1 288)
(1 201)
(1 176)
(1 215)
(459)
(453)
(459)
(411)
(323)
(391)
(391)
(389)
(148)
(3 948)
(8 216)
Gain/Loss on Disposition of Assets
(22)
(24)
(28)
(82)
(25)
(23)
1 350
1 301
1 334
1 332
(107)
(162)
(182)
(173)
(96)
(56)
(62)
(61)
(105)
(59)
544
521
460
988
410
429
(64)
(70)
(82)
(80)
80
86
90
94
(52)
(51)
(50)
(53)
(59)
(64)
(61)
Total Other Income
522
535
543
405
409
374
193
(87)
(220)
(305)
1 523
1 513
1 321
1 291
857
817
880
2 030
734
803
896
790
1 379
2 375
2 839
2 556
1 273
1 219
991
993
898
922
950
752
821
823
787
896
777
809
723
Pre-Tax Income
18 587
N/A
18 567
0%
19 713
+6%
20 056
+2%
20 930
+4%
20 797
-1%
21 715
+4%
18 755
-14%
20 865
+11%
20 508
-2%
19 802
-3%
24 617
+24%
22 987
-7%
25 627
+11%
22 572
-12%
23 160
+3%
23 534
+2%
25 478
+8%
25 304
-1%
24 789
-2%
25 838
+4%
27 050
+5%
26 804
-1%
48 047
+79%
47 610
-1%
47 667
+0%
26 635
-44%
26 865
+1%
26 790
0%
26 664
0%
27 636
+4%
27 557
0%
27 459
0%
27 114
-1%
27 950
+3%
27 950
N/A
28 155
+1%
28 718
+2%
27 559
-4%
24 048
-13%
18 749
-22%
Net Income
Tax Provision
(6 828)
(6 762)
(6 983)
(7 608)
(8 017)
(7 799)
(7 489)
(5 300)
(5 091)
(4 976)
(5 544)
(6 904)
(6 893)
(7 708)
(6 709)
(6 931)
(7 078)
(7 588)
(7 280)
(7 144)
(7 483)
(7 790)
(7 665)
(13 604)
(13 210)
(13 270)
(7 430)
(7 774)
(7 922)
(7 834)
(7 920)
(7 996)
(7 924)
(7 781)
(7 927)
(7 792)
(7 965)
(7 695)
(7 221)
(6 342)
(4 841)
Income from Continuing Operations
11 759
11 805
12 730
12 448
12 913
12 998
14 226
13 455
15 774
15 532
14 258
17 713
16 094
17 919
15 863
16 229
16 456
17 890
18 024
17 645
18 355
19 260
19 139
34 443
34 400
34 397
19 205
19 091
18 868
18 830
19 716
19 561
19 535
19 333
20 023
20 158
20 190
21 023
20 338
17 706
13 908
Income to Minority Interest
0
0
0
0
2
11
4
10
26
27
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
0
0
0
Net Income (Common)
11 760
N/A
11 808
+0%
12 730
+8%
12 448
-2%
12 915
+4%
13 008
+1%
14 230
+9%
13 466
-5%
15 801
+17%
15 561
-2%
14 321
-8%
17 776
+24%
16 139
-9%
17 952
+11%
15 863
-12%
16 229
+2%
16 455
+1%
17 890
+9%
18 023
+1%
17 643
-2%
18 354
+4%
19 259
+5%
19 139
-1%
34 443
+80%
34 400
0%
34 397
0%
19 205
-44%
19 091
-1%
18 868
-1%
18 830
0%
19 715
+5%
19 560
-1%
19 534
0%
19 332
-1%
20 022
+4%
20 157
+1%
20 186
+0%
21 020
+4%
20 338
-3%
17 706
-13%
13 910
-21%
EPS (Diluted)
143.41
N/A
145.77
+2%
157.16
+8%
151.8
-3%
159.44
+5%
158.63
-1%
173.53
+9%
165.3
-5%
197.51
+19%
194.51
-2%
178.85
-8%
225.01
+26%
204.29
-9%
227.24
+11%
201.02
-12%
205.43
+2%
208.29
+1%
226.45
+9%
227.95
+1%
223.47
-2%
234.1
+5%
246.41
+5%
244.07
-1%
440.65
+81%
440.1
0%
440.06
0%
245.7
-44%
244.25
-1%
241.39
-1%
240.91
0%
252.35
+5%
252.67
+0%
252.77
+0%
250.16
-1%
259.58
+4%
264.98
+2%
265.15
+0%
276.11
+4%
268.16
-3%
238.18
-11%
187.17
-21%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.